SCHEMBL2720015

SCHEMBL2720015

C=CCOc1cccc(C(NC2CCN(C)CC2)c2nc3ccccc3[nH]2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD3 P35462 2/20 0.38
▸ DRD2 P14416 1/20 0.38
▸ MGLL Q99685 1/20 0.37
▸ SYK P43405 1/20 0.36
▸ KCNH2 Q12809 1/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ DUT P33316 1/20 0.35
▸ HRH4 Q9H3N8 1/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ LMNA P02545 3/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ PDE10A Q9Y233 2/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ TP53 P04637 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ TSHR P16473 1/20 0.33
▸ ADRA2A P08913 1/20 0.33
▸ ADRA2B P18089 1/20 0.33
▸ ADRA2C P18825 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2721367 0.92 DRD3 (0.40) DRD3DRD2KCNH2HRH4SMN1; SMN2
SCHEMBL2720270 0.91 DRD3 (0.40) DRD3DRD2KCNH2HRH4LMNA
SCHEMBL900249 0.89 MAPT (0.42) DRD3DRD2KCNH2NPC1RAB9A
SCHEMBL2721839 0.89 DRD3 (0.43) DRD3DRD2KCNH2NPC1SMN1; SMN2
SCHEMBL2720206 0.88 DRD3 (0.39) DRD3DRD2SYKKCNH2NPC1
SCHEMBL2722268 0.88 DRD3 (0.42) DRD3DRD2KCNH2RAB9AHRH4
SCHEMBL2721632 0.87 DRD3 (0.42) DRD3DRD2KCNH2NPC1RAB9A
SCHEMBL2719981 0.87 PRMT5 (0.41) DRD3DRD2KCNH2NPC1RAB9A
SCHEMBL2720512 0.87 DRD3 (0.42) DRD3DRD2KCNH2LMNAPDE10A
SCHEMBL2720352 0.86 ALDH1A1 (0.44) DRD3DRD2KCNH2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3378476-A1 H4 RECEPTOR INHIBITORS FOR TREATING TINNITUS Sensorion (FR) 2018-09-26 — — EP disclosed
US-9688989-B2 H4 receptor inhibitors for treating tinnitus SENSORION (FR) 2017-06-27 — — US disclosed
EP-2621916-B1 BENZAZOLE DERIVATIVES AS HISTAMINE H4 RECEPTOR LIGANDS BIOPROJET SOC CIV (FR) 2016-02-10 — — EP disclosed
US-20150176010-A1 H4 RECEPTOR INHIBITORS FOR TREATING TINNITUS SENSORION (FR) 2015-06-25 — — US disclosed
EP-2447263-A1 Benzazole derivatives as histamine H4 receptor ligands BIOPROJET (FR) 2012-05-02 — — EP disclosed
Send feedback